Differential effects of interleukin-1β and S100B on amyloid precursor protein in rat retinal neurons
Author(s) -
Peter J. Anderson
Publication year - 2009
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s2684
Subject(s) - retinal , nissl body , amyloid precursor protein , senile plaques , bace1 as , in vivo , blot , amyloid beta , pathogenesis , microbiology and biotechnology , medicine , chemistry , neuroscience , biology , alzheimer's disease , pathology , staining , biochemistry , ophthalmology , gene , disease
Interleukin-1beta (IL-1beta) and S100B calcium binding protein B (S100B) have been implicated in the pathogenesis of Alzheimer's disease. Both are present in and around senile plaques and have been shown to increase levels of amyloid precursor protein (APP) mRNA in vitro. However, it is not known how either of these substances affects APP in vivo.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom